Literature DB >> 7758170

Thrombin induces the preproendothelin-1 gene in endothelial cells by a protein tyrosine kinase-linked mechanism.

T A Marsen1, M S Simonson, M J Dunn.   

Abstract

Thrombin stimulates synthesis and secretion of endothelin-1 (ET-1), a vasoactive peptide that triggers responses in the vascular endothelium and smooth muscle. We investigated the signal transduction pathways by which thrombin stimulates preproET-1 gene expression and ET-1 peptide secretion in macrovascular cells (human umbilical vein endothelial cells [HUVECs] and bovine pulmonary artery endothelial cells [BPAECs]) and microvascular cells (human microvascular endothelial cell line [HMEC-1]). Thrombin (4 U/mL) stimulated maximal induction of ET-1 peptide secretion and preproET-1 mRNA after 2 hours in HUVECs and BPAECs and after 1 hour in HMEC-1. A synthetic thrombin receptor activator peptide confirmed ligand-specific receptor actions to induce preproET-1 mRNA. Protein kinase C (PKC) activation by phorbol ester transiently induced preproET-1 mRNA but had no effect on ET-1 peptide synthesis. PKC inhibitors sangivamycin and calphostin C and PKC depletion failed to suppress thrombin-stimulated preproET-1 mRNA. Adenylate cyclase and cAMP-dependent protein kinase did not participate in thrombin-induced preproET-1 gene activation. Thrombin stimulated a rapid increase in phosphotyrosine-containing proteins, suggesting a role for tyrosine phosphorylation in thrombin signaling. These data demonstrate that thrombin induces the preproET-1 gene and ET-1 peptide synthesis by a PKC-independent PTK-dependent pathway in macrovascular and microvascular endothelial cells. Protein tyrosine kinase inhibitors herbimycin A and genistein blocked thrombin-stimulated preproET-1 mRNA and peptide secretion, whereas daidzein, which lacks inhibitory activity, did not suppress thrombin-induced ET-1.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7758170     DOI: 10.1161/01.res.76.6.987

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  6 in total

1.  Matrix Metalloproteinase 1 Causes Vasoconstriction and Enhances Vessel Reactivity to Angiotensin II via Protease-Activated Receptor 1.

Authors:  William H Nugent; Nikita Mishra; Jerome F Strauss; Scott W Walsh
Journal:  Reprod Sci       Date:  2015-10-04       Impact factor: 3.060

2.  Endothelin alters the reactivity of vasa vasorum: mechanisms and implications for conduit vessel physiology and pathophysiology.

Authors:  R Scotland; P Vallance; A Ahluwalia
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

Review 3.  Endothelin-1 gene regulation.

Authors:  Lisa R Stow; Mollie E Jacobs; Charles S Wingo; Brian D Cain
Journal:  FASEB J       Date:  2010-09-13       Impact factor: 5.191

4.  Plasma endothelin-1 concentrations in patients with retinal vein occlusions.

Authors:  A Iannaccone; C Letizia; S Pazzaglia; E M Vingolo; G Clemente; M R Pannarale
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

5.  Suppression of prostanoid formation and regulation of peripheral circulation after surgery using thrombin inhibitor (MD805).

Authors:  M Onizuka; S Ishikawa; O Ishibashi; M Suga; K Mitsui; T Mitsui
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

6.  Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen.

Authors:  Z Chen; I S Yuhanna; Z Galcheva-Gargova; R H Karas; M E Mendelsohn; P W Shaul
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.